0460.HK fell 4.17% to HK $1.15, with a total market capitalization of HK $10.7 billion, after surging more than 24% in intraday trading yesterday. Sihuan Pharmaceutical announced after trading yesterday that the company's board of directors took note of several media articles on May 12, 2022 claiming that the group was in talks with potential investors on privatisation and disclosed relevant valuation and privatisation pricing and other information. The Group hereby declares that the above news is not true. After all reasonable enquiries against the Company, the Board confirms that the above report does not constitute inside information required to be disclosed under part XIVA of the Securities and Futures Ordinance (Cap. 571), nor is the Board aware of any information that must be disclosed to avoid false markets in the Company's securities or any other inside information.